CRISPR: A Game Changing Technology for a More Equitable Future

2016 was a landmark year for the biotechnology industry as it was for the first time that the revolutionary CRISPR-Cas9 gene-editing technique was used in humans. With more human trials involving CRISPR-Cas9 scheduled to be conducted, I believe 2017 will be the year when the technology’s potential to treat human diseases could receive strong clinical … Continue reading CRISPR: A Game Changing Technology for a More Equitable Future

Biocon Advances In War Against Diabetes

There are nearly half a billion diabetes patients in the world. The alarming growth in the global diabetes population is leading to a huge demand for effective therapies from pre/early diabetes to late-stage disease. Of the 100 million people who need insulin globally, however, only ‘one in two’ can manage and afford costs associated with … Continue reading Biocon Advances In War Against Diabetes

Innovation, not price control is the answer to affordable Bt cotton technology

The biggest threat to cotton farmers is the bollworm, because of its ability to cause extraordinary damage to crops and livelihoods. In the 1990s, pesticides were the only weapon farmers had against the bollworm. Half of all the pesticide consumption in India was accounted for by just one crop – cotton. Yet, the ability of … Continue reading Innovation, not price control is the answer to affordable Bt cotton technology

Pharma & Biotech Sector Must Get Its Due This Budget

Finance Minister Arun Jaitley has a challenging task at hand to present a Budget for FY17 that spurs India’s growth at a time when the economic scenario appears challenging, both externally and internally. The global economy is expected to slow down further in 2016 pulled down by weakness in major emerging economies like China, Brazil … Continue reading Pharma & Biotech Sector Must Get Its Due This Budget

IP Creation Can Make India the Next Global Innovation Hub

In today’s world, technology is playing a transformational role in enabling innovation and driving change. New ideas, new business models and new technologies are leading to the birth of the “ideas economy,” where the “innovation quotient” has emerged as the key determinant of market value. India will lose out on the opportunity to benefit from innovation-led, … Continue reading IP Creation Can Make India the Next Global Innovation Hub

Why FY14 was a Remarkable Year for Biocon

The fiscal year gone by has been one of the most exciting ones for Biocon. We delivered on our promise of affordable innovation, recorded robust top line and bottom line growth, augmented our capacities, optimized our product portfolio and introduced initiatives to achieve operational efficiencies. We successfully commercialized two world-class, low-cost monoclonal antibodies, an outcome … Continue reading Why FY14 was a Remarkable Year for Biocon

Women at Work: Biocon Founder on Philanthropy, Sexism and Politics

In the first in a series of interviews with women who are leaders in their field in India, The Wall Street Journal’s India Real Time met Kiran Mazumdar-Shaw, the founder of biotechnology company Biocon Ltd. 532523.BY +0.16%, and one of India’s richest women. Last month, Ms. Mazumdar-Shaw was named by Forbes as one of the most generous people in Asia. … Continue reading Women at Work: Biocon Founder on Philanthropy, Sexism and Politics

Indian pharma companies need to be surefooted in their approach to quality

By Kiran Mazumdar Shaw The hefty fine that Ranbaxy Laboratories will pay as part of the drug safety settlement in the US threatens to seriously erode its reputation that can take years to regain. This is particularly sad as Ranbaxy has been a leader and stalwart among Indian generic drug makers that have, over the … Continue reading Indian pharma companies need to be surefooted in their approach to quality